Brief: NeurAxis Will Disclose In Form 10-K For Year Ended December 31, 2023, Material Weakness On Its Internal Controls Over Financial Reporting
April 9 (Reuters) - NeurAxis Inc NRXS.A :
* NEURAXIS- WILL DISCLOSE IN FORM 10-K FOR YEAR ENDED
DECEMBER 31,
2023, MATERIAL WEAKNESS ON ITS INTERNAL CONTROLS OVER FINANCIAL
REPORTING
* NEURAXIS: TO DISCLOSE IN FORM 10-K FOR YEAR ENDED DEC 31,
2023,
RESTATED FINANCIAL STATEMENTS FOR THREE & NINE MONTH PERIOD
ENDED SEPT 30, 2023
* NEURAXIS- ON APRIL 4, CONCLUDED PREVIOUSLY ISSUED
FINANCIAL
STATEMENTS FOR 3 & 9 MONTHS PERIOD ENDED SEPT 30, 2023 SHOULD NO
LONGER BE RELIED UPON
* NEURAXIS INC - ERROR DOES NOT CHANGE THE CASH POSITION OF
THE
COMPANY AS OF SEPTEMBER 30, 2023
Source text for Eikon: [ID:https://bitly.ws/3hKNJ]
Further company coverage: NRXS.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuraxis
See all newsBrief: NeurAxis - Q2 2026 Revenues Increased 116% Year Over Year To $1.90 Million
Brief: Neuraxis - Files To Register Resale Of Up To 1,923,194 Shares Of Common Stock - SEC Filing
Brief: Neuraxis Inc Expects Net Sales Of About $1.6 Million For Three Months Ended March 31, 2026
Brief: Neuraxis Reports Strong Fourth Quarter And Full Year 2025 Financial Results
Brief: Neuraxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access To More Patients With Functional Abdominal Pain